Surrey Clinical Research Centre achieves MHRA accreditation

17 June 2010

The Medicines and Healthcare products Regulatory Agency (MHRA) has awarded the Surrey Clinical Research Centre (Surrey CRC) at the University of Surrey standard accreditation for conducting clinical pharmacology Phase I trials.

The accreditation scheme was introduced to improve the safety of clinical research volunteers and assesses the capability of the clinical research centre based on facilities, training and experience of staff. The accreditation gives additional reassurance and confidence that the Surrey CRC meets the highest of industry clinical research standards.

Dr Julia Boyle, Director of Surrey CRC, said: "I am very proud to announce the accreditation of the Surrey CRC by the MHRA. Our accreditation success reflects the strong commitment of the University of Surrey — and in particular the Surrey CRC team — to excellence and high-quality research. The Surrey CRC is embedded in an academic environment with international recognition for clinical research. In addition to our academic strength, the accreditation places us firmly alongside the best commercial clinical research organisations in the UK."

The Surrey Clinical Research Centre has a particular emphasis on sleep and human psychopharmacology. To date it has undertaken over 250 clinical trials including both volunteer and patient populations.